Cargando…
A novel neutrophil extracellular trap signature to predict prognosis and immunotherapy response in head and neck squamous cell carcinoma
Head and neck squamous cell carcinoma (HNSCC) is one of the most common malignant cancers, and patients with HNSCC possess early metastases and poor prognosis. Systematic therapies (including chemotherapy, targeted therapy, and immunotherapy) are generally applied in the advanced/late stages of HNSC...
Autores principales: | Li, Qilin, Chen, Weimin, Li, Qiuhui, Mao, Jing, Chen, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549764/ https://www.ncbi.nlm.nih.gov/pubmed/36225931 http://dx.doi.org/10.3389/fimmu.2022.1019967 |
Ejemplares similares
-
A Neutrophil Extracellular Traps Signature Predicts the Clinical Outcomes and Immunotherapy Response in Head and Neck Squamous Cell Carcinoma
por: Chen, Naifei, et al.
Publicado: (2022) -
Neutrophil extracellular traps in tumor progression and immunotherapy
por: Yan, Meina, et al.
Publicado: (2023) -
Noninvasive evaluation of neutrophil extracellular traps signature predicts clinical outcomes and immunotherapy response in hepatocellular carcinoma
por: Xin, Hongjie, et al.
Publicado: (2023) -
A signature for pan-cancer prognosis based on neutrophil extracellular traps
por: Zhang, Yi, et al.
Publicado: (2022) -
Excessive Neutrophils and Neutrophil Extracellular Traps in COVID-19
por: Wang, Jun, et al.
Publicado: (2020)